506 results on '"Sharma, Sherven"'
Search Results
52. Immune Checkpoint Blockade Enhances Immune Activity of Therapeutic Lung Cancer Vaccine
53. CD14+S100A9+ Myeloid-derived Suppressor Cells Portend Decreased Survival in Patients with Advanced Lung Cancer
54. Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non–small cell lung cancer
55. Immunologic Mechanisms in Lung Carcinogenesis and Metastasis
56. A Novel Modular Polymer Platform for the Treatment of Head and Neck Squamous Cell Carcinoma in an Animal Model
57. Myeloid suppressor cells and immune modulation in lung cancer
58. PD-1 Immune Checkpoint Blockade Promotes Therapeutic Cancer Vaccine to Eradicate Lung Cancer
59. The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy
60. Chemoprevention Strategies with Cyclooxygenase-2 Inhibitors for Lung Cancer
61. A novel modular polymer platform for the treatment of HNSCC
62. Towards effective immunotherapy for lung cancer: simultaneous targeting of tumor-initiating cells and immune pathways in the tumor microenvironment
63. CCL21-DC tumor antigen vaccine augments anti-PD-1 therapy in lung cancer.
64. Smoking and Lung Cancer: The Role of Inflammation
65. EGFR Signaling Is Required for TGF-β1-Mediated COX-2 Induction in Human Bronchial Epithelial Cells
66. Inflammation and lung carcinogenesis: applying findings in prevention and treatment
67. Utility of Adenoviral Vectors in Animal Models of Human Disease I
68. Gene Transfer Mediated by Native versus Fibroblast Growth Factor-Retargeted Adenoviral Vectors into Lung Cancer Cells
69. Multifaceted roles of cyclooxygenase-2 in lung cancer
70. Cocaine modulates cytokine and enhances tumor growth through sigma receptors
71. Cyclooxygenase-2-Dependent Expression of Survivin in Non-small Cell Lung Cancer*
72. CXC Chemokines: Angiogenesis, Immunoangiostasis, and Metastases in Lung Cancer
73. IL-7 inhibits fibroblast TGF-β production and signaling in pulmonary fibrosis
74. New Gene and Cell-Based Therapies for Lung Cancer
75. Adenoviral Gene Transfer Is Inhibited by Soluble Factors in Malignant Pleural Effusions
76. Tumor Antigens in Thoracic Malignancy
77. Early intervention with a small molecule inhibitor for tumor nefosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer’s disease
78. Abstract 3214: In situ vaccination with CCL21-modified dendritic cells (CCL21-DC) combined with checkpoint blockade in murine models of NSCLC
79. Abstract CT226: A Phase I trial ofin situvaccination with autologousCCL21-modified dendritic cells (CCL21-DC) combined with pembrolizumab for advanced NSCLC
80. miR-200c Modulates the Pathogenesis of Radiation-Induced Oral Mucositis
81. Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage–colony-stimulating factor and interleukin-4
82. Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer
83. Down-regulation of murine fibrosarcoma transforming growth factor-beta-1 expression by interleukin 7
84. Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells
85. SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10
86. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma
87. Use of a Novel Polymer in an Animal Model of Head and Neck Squamous Cell Carcinoma
88. Inhibiting C5a/C5aR axis reduces myeloid-derived suppressor cells and enhances PD-1 blockade therapy in lung cancer
89. MA09.07 Phase I Trial of in situ Vaccination with CCL21 Gene-Modified DC Induces Specific Systemic Immune Response and Tumor Infiltrating CD8+ T Cells
90. Abstract 5170: Snail-dependent ESRP1 silencing drives malignant conversion of human pulmonary epithelial cells
91. Abstract 2324: FRA1 contributes to ERK-mediated increased PD-L1 expression in KRAS mutated premalignant human bronchial epithelial cells
92. Abstract 1723: Novel drug candidates CEP1430 and CEP1507 against cancer stem cells and circulating tumor cells in advanced stage pancreatic cancer
93. Increased PD-L1 expression in KRAS mutated premalignant human bronchial epithelial cells is enhanced by LKB1 loss and mediated by ERK activation
94. Elevated neutrophil gelatinase-associated lipocalin contributes to erlotinib resistance in non-small cell lung cancer
95. Effect of epigenetic histone modifications on E-cadherin splicing and expression in lung cancer
96. CCL21 Chemokine Therapy for Lung Cancer
97. Sodium Butyrate Inhibits Colorectal Cancer Cell Migration by Downregulating Bmi‐1 Through Enhanced miR‐200c Expression.
98. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
99. Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer
100. A Novel Modular Polymer Platform for the Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC) in an Animal Model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.